Emily M. Cowley’s Insights

168 total results. Page 1 of 14.

Alerts
Here Comes the Sun(screen): FDA Greenlights Bemotrizinol as Active Ingredient
Alerts
Gene Editing for Human Therapies Just Got a Shortcut: What the FDA’s New Draft Guidance Means for Your Business
Alerts
Pay(or) Attention, Drug and Device Makers: FDA’s New Guidance for Talking to Health Plans
Alerts
US Supreme Court Restores Access to Mifepristone — For Now*
Longevity Lens
The Shot Heard ‘Round the Pharmacy’: FDA Takes Aim at GLP-1 Compounders
Alerts
DOJ Moves FDA Approved and Medical Marijuana to Schedule III
Events
2026 Chicago Pharma Forum
Alerts
Navigating the 2026 Life Sciences Legal Landscape
Alerts
NDSee You in 2033: FDA’s 12‑Digit NDC Is Coming
Alerts
High Standards: Protecting Workers in Cannabis Cultivation and Manufacturing
Alerts
Top Issues in the Cannabis Industry for 2026
Events
Webinar: FDA Regulatory Update Series for Cosmetics & Personal Care Products: Spotlight on Talc-Asbestos Testing and What Comes Next